[1]
N. Schuelper, B. Chapuy, T. Relander, L. Truemper, and G. Wulf, “Preclinical evaluation of sorafenib against B- and T-cell lymphoma”, Hematol Meeting Rep, vol. 3, no. 1, Jun. 2009.